Newsletter | Yinfeng Low Temperature was invited to participate in the "International Conference on Health and Behavioral Science"
Release time:
2022-12-19
On December 19, 2022, the International Conference on Health and Behavioral Sciences, hosted by Shandong University of Finance and Economics, was successfully held. Yinfeng Cryogen, as a high-profile leader in the development of cryogenic medicine, was invited to attend the meeting.
The conference was launched online, aiming to introduce the cutting-edge theoretical progress and benchmarking industry practice of the international medical care and health industry into our province, and provide international experience and think tank suggestions for the implementation of the "top ten industries" in our province. The conference invited outstanding entrepreneurs in the industry to conduct online exchanges and share excellent papers, mainly focusing on the prevention of infectious diseases of the new crown epidemic, applied behavioral science to prevent and control epidemics, translational medicine and innovation, health quality and medical safety, the developing medical and health field, public health emergency management practice, traditional Chinese medicine management and overseas communication, health care, welfare and sustainable development and other topics.
In this meeting, Yinfeng Cryogenic introduced the vision of Yinfeng Biological Group and the whole life cycle health management service, which echoed the theme of "great health" of this conference. Relying on the whole chain of bioengineering industry such as cell and tissue organ storage, gene sequencing technology, cell application technology, cryogenic medical technology, health management and other bioengineering industries independently built by Yinfeng Biology, the whole life cycle health management continuously extends and integrates the resources of big health products and services according to the specific health risk factors at each stage of the cycle of human life from the beginning of germ cell integration to the final termination of life, and provides customers with one-stop, personalized and multi-scenario prevention and intervention services through online and offline forms.
In recent years, cryomedicine has attracted much attention due to its fruitful clinical application results and strong development momentum. Under the concept of the whole life cycle, the "life extension plan" was introduced, and the cryopreservation and resuscitation technology of various human tissues and organs including ovarian tissue, skin, severed fingers (toes), valves, blood vessels and other human tissues and organs has been mastered in detail.
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155515
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
